José Chang
Impact in
- Hematology top 5%
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Oncology top 10%
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 4
- Neutropenia and Cancer Infections 3
- Cancer survivorship and care 2
- HER2/EGFR in Cancer Research 2
- Cutaneous Melanoma Detection and Management 1
-
- Erythropoietin and Anemia Treatment 5
- Co-authors
- Félix Couture (5 shared papers)Catherine Y. Lau (3 shared papers)Scott Young (1 shared paper)George Dranitsaris (2 shared papers)Daniel Rayson (2 shared papers)Karen A. Gelmon (2 shared papers)Mark Vincent (2 shared papers)Wanfu Xu (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)The Oncologist (2 papers)European Journal of Cancer (1 paper)Journal of Oncology Practice (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
José Chang
17 papers receiving 603 citations
Peers
Comparison fields: 5 of 55
- Hematology 157
- Oncology 288
- Genetics 54
- Pulmonary and Respiratory Medicine 141
- Biochemistry 21
Countries citing papers authored by José Chang
This map shows the geographic impact of José Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Chang more than expected).
Fields of papers citing papers by José Chang
This network shows the impact of papers produced by José Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Chang. The network helps show where José Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside José Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 139 | |
| 2 | 2000 | 93 | |
| 3 | 2010 | 71 | |
| 4 | 2009 | 64 | |
| 5 | 2007 | 50 | |
| 6 | 2008 | 43 | |
| 7 | 2002 | 37 | |
| 8 | 2013 | 24 | |
| 9 | 2008 | 23 | |
| 10 | 2004 | 19 | |
| 11 | 2004 | 17 | |
| 12 | 2012 | 10 | |
| 13 | 2006 | 8 | |
| 14 | 2013 | 7 | |
| 15 | Safety of Dual Antiplatelet Therapy After Carotid Endarterectomy for Prevention of Restenosis: A Single Center Experience. | 2016 | 5 |
| 16 | 2021 | 3 | |
| 17 | 2005 | 2 |
About José Chang
José Chang is a scholar working on Oncology, Hematology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Dermatology, having authored 17 papers that have together received 615 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (5 papers), Cancer Treatment and Pharmacology (4 papers), Neutropenia and Cancer Infections (3 papers), Cancer-related cognitive impairment studies (2 papers), Cancer survivorship and care (2 papers), HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (1 paper) and Cutaneous Melanoma Detection and Management (1 paper). The work is most often cited by research in Hematology (157 citations), Oncology (288 citations), Genetics (54 citations), Pulmonary and Respiratory Medicine (141 citations) and Biochemistry (21 citations). José Chang has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Félix Couture, Catherine Y. Lau, Scott Young, George Dranitsaris, Daniel Rayson, Karen A. Gelmon, Mark Vincent, Wanfu Xu, Kathleen I. Pritchard and M. Macpherson. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, The Oncologist, European Journal of Cancer and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.